New York State Common Retirement Fund Omega Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.86 - $3.2 $25,783 - $44,358	-13,862 Reduced 98.44%	220 $0
Q1 2024 May 07, 2024	SELL	$2.73 - $5.32 $76 - $148	-28 Reduced 0.2%	14,082 $51,000
Q4 2023 Feb 01, 2024	SELL	$1.35 - $3.21 $78 - $186	-58 Reduced 0.41%	14,110 $42,000
Q3 2023 Nov 07, 2023	BUY	$2.15 - $5.68 $576 - $1,522	268 Added 1.93%	14,168 $30,000
Q2 2023 Aug 07, 2023	BUY	$5.6 - $9.66 $77,840 - $134,274	13,900 New	13,900 $78,000
Q2 2022 Aug 04, 2022	SELL	$2.01 - $7.19 $37,767 - $135,100	-18,790 Reduced 98.79%	230 $1,000
Q1 2022 May 05, 2022	BUY	$6.24 - $14.04 $91,104 - $204,984	14,600 Added 330.32%	19,020 $119,000
Q4 2021 Feb 02, 2022	BUY	$11.33 - $29.38 $50,078 - $129,859	4,420 New	4,420 $50,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $23.4M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.